2-(4-methoxyphenyl)-1H-quinazolin-4-one and Neoplasms

2-(4-methoxyphenyl)-1H-quinazolin-4-one has been researched along with Neoplasms* in 1 studies

Reviews

1 review(s) available for 2-(4-methoxyphenyl)-1H-quinazolin-4-one and Neoplasms

ArticleYear
Small-Molecule Inhibitors of Tankyrases as Prospective Therapeutics for Cancer.
    Journal of medicinal chemistry, 2022, 04-14, Volume: 65, Issue:7

    Tankyrases are multifunctional poly(adenosine diphosphate-ribose) polymerases that regulate diverse biological processes including telomere maintenance and cellular signaling. These processes are often implicated in a number of human diseases, with cancer being the most prevalent example. Accordingly, tankyrase inhibitors have gained increasing attention as potential therapeutics. Since the discovery of XAV939 and IWR-1 as the first tankyrase inhibitors over two decades ago, tankyrase-targeted drug discovery has made significant progress. This review starts with an introduction of tankyrases, with emphasis placed on their cancer-related functions. Small-molecule inhibitors of tankyrases are subsequently delineated based on their distinct modes of binding to the enzymes. In addition to inhibitors that compete with oxidized nicotinamide adenine dinucleotide (NAD

    Topics: Catalytic Domain; Drug Discovery; Humans; Neoplasms; Tankyrases

2022